Abstract
This is the second article in the series of “Nuclear Medicine Updates.” Upon completion of this article, the technologist will: (1) have an awareness of an alternate method for evaluation of ischemic coronary artery disease (CAD) on patients who are unable to exercise on a treadmill and (2) have a guideline avaiable to them for the use of dipyridamole.
